Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference product sponsors…
Read More →In the past few months, the administration, the Copyright Office, and the courts have weighed in on several material issues…
Read More →Under Dickinson v. Zurko courts (specifically, the Federal Circuit) should defer to factual determinations by administrative agencies like the U.S.…
Read More →On August 8, 2025, the U.S. Department of Commerce sent a letter to Harvard University—also shared publicly on the social…
Read More →President Trump’s “Working Group on Digital Asset Markets” recently released a report with a strategic roadmap to advance American leadership…
Read More →Uber Technologies (Uber) is currently facing more than 2,500 lawsuits in federal court alleging that the company is liable for…
Read More →Following multiple enhancements to Sophos Email – the only MDR-optimized email security solution – Sophos is introducing two new offerings…
Read More →Key point: Colorado’s Department of Law is soliciting public comments through September 5, 2025, on revised privacy rules to protect…
Read More →Last week, the White House released a landmark report on digital financial technology, signaling a coordinated federal push to modernize…
Read More →BMF Publishes Draft Bill on DAC 8 Implementation Act – On 26 June 2025, the German Federal Ministry of Finance…
Read More →